FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

MATTHEWS TERENCE H
2. Issuer Name and Ticker or Trading Symbol

COUNTERPATH CORP [ CPAH ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chairman
(Last)          (First)          (Middle)

390 MARCH ROAD, SUITE 110
3. Date of Earliest Transaction (MM/DD/YYYY)

7/20/2017
(Street)

KANATA, A6 K2K 0G7
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares                  1237304   I   Wesley Clover International Corporation   (2)
Common Shares   7/20/2017     P    144357   A $2.20   1381661   I   Wesley Clover International Corporation   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Share Units     (1)                  12/14/2009     (1) Common   4838.7     4838.7   D    
Deferred Share Units     (1)                  6/18/2010     (1) Common   3000.0     7838.7   D    
Deferred Share Units     (1)                  7/25/2011     (1) Common   1621.6     9460.3   D    
Deferred Share Units     (1)                  7/19/2012     (1) Common   1539.7     11000.0   D    
Deferred Share Units     (1)                  7/25/2013     (1) Common   2262.5     13262.5   D    
Deferred Share Units     (1)                  7/11/2014     (1) Common   3427.4     16689.9   D    
Deferred Share Units     (1)                  7/17/2015     (1) Common   7211.3     23901.2   D    
Deferred Share Units     (2)                  7/14/2016     (2) Common   15345.0     39246.2   D    
Deferred Share Units     (2)                  7/14/2017     (2) Common   16943     56189.2   D    

Explanation of Responses:
(1)  Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. The deferred share units vest immediately.
(2)  On January 1, 2017, Wesley Clover International Corporation and Kanata Research Park Corporation amalgamated under the new name of Wesley Clover International Corporation. Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
MATTHEWS TERENCE H
390 MARCH ROAD, SUITE 110
KANATA, A6 K2K 0G7
X X Chairman

Signatures
/s/Terence Matthews 7/31/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CounterPath (NASDAQ:CPAH)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more CounterPath Charts.
CounterPath (NASDAQ:CPAH)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more CounterPath Charts.